YY1 in hematopoietic stem cells: epigenetic regulation, chromatin architecture, and aging Authors: Yinghua Wang, Xuan Pan Published: 2026 ABSTRACT AbstractPurpose of ReviewYin Yang 1 (YY1) is a multifunctional transcription factor (TF) with established roles in lymphocyte development. More recently, its functions as a Polycomb group (PcG) protein and chromatin structural regulator in the hematopoietic system have gained increasing attention. This mini-review summarizes emerging insights into the epigenetic and architectural roles of YY1 in fetal and adult hematopoietic stem cells (HSCs), extending beyond its classical transcriptional activity. We also discuss how altered YY1 function contributes to HSC aging and hematopoietic decline.Recent FindingsRecent studies show that YY1 is essential for maintaining HSC quiescence, self-renewal, and engraftment during both fetal and adult hematopoiesis. Mechanistically, YY1 regulates hematopoiesis through PcG-dependent pathways and by shaping higher-order chromatin organization. It mediates long-range chromatin interactions, cooperates with cohesin and CTCF to organize three-dimensional genome architecture, and coordinates transcriptional and metabolic programs critical for stem cell maintenance. Notably, age-associated reductions in YY1 activity are linked to functional impairment of HSCs, implicating YY1 in hematopoietic aging.SummaryYY1 acts as a TF, chromatin organizer, and PcG protein in hematopoiesis. Defining its roles in normal and aging HSCs may reveal mechanisms of hematopoietic decline and inform strategies to preserve blood system function.Keywords: chromatin structural regulator, hematopoietic stem cells, Polycomb group, Yin Yang 1 INTRODUCTION Yin Yang 1 (YY1) is a ubiquitously expressed and highly conserved transcription factor (TF) that integrates sequence-specific DNA binding with epigenetic and chromatin-based regulatory functions. YY1 can both activate and repress transcription [1,2], and beyond direct transcriptional regulation, it contributes to higher-order genome organization by mediating long-range DNA interactions between proximal and distal regulatory elements through homodimerization [3–8,9▪▪]. In addition, YY1 cooperates with Polycomb group (PcG) complexes by recruiting PcG components to chromatin and modulating histone modifications, thereby leading to stable epigenetic repression [10–13]. Consistent with these multifunctional properties, YY1 plays essential roles in early embryonic development, X-chromosome inactivation (XCI), DNA damage repair, hematopoiesis, and hematologic malignancies [14–18,19▪]. Initially identified through its binding at immunoglobulin loci, YY1 was subsequently shown to be indispensable for both B- and T-lymphocyte development, highlighting its importance in the hematopoietic system [16,20–25]. More recently, YY1 has emerged as a critical regulator of hematopoietic stem cell (HSC) biology, where it controls self-renewal, quiescence, and engraftment in both fetal and adult contexts [26▪▪,27,28]. Although YY1 directly regulates a limited subset of target genes, such as Kit [27] and the cohesin component SMC3 [28], genome-wide studies reveal that most transcriptional alterations following YY1 loss occur at loci not directly bound by YY1 [26▪▪], supporting a broader role in shaping chromatin accessibility and epigenomic landscapes. These findings suggest that YY1 functions not only as a classical TF but also as a chromatin architectural regulator, coordinating gene expression programs in hematopoietic stem progenitor cells (HSPCs). In this review, we summarize current understanding of YY1 function in HSCs, with particular emphasis on its roles in PcG-mediated repression and chromatin structural regulation during fetal and adult hematopoiesis. no caption available YIN YANG 1 FUNCTIONS IN HEMATOPOIETIC STEM CELL Genetic and mechanistic studies have established YY1 as an essential regulator of HSC function during both fetal and adult hematopoiesis [25,26▪▪,27,28]. In the adult hematopoietic system, conditional deletion of Yy1 results in severe pancytopenia and a marked reduction in long-term HSC repopulating capacity, whereas ectopic YY1 expression promotes HSC expansion. YY1 deficiency disrupts transcriptional networks governing HSC proliferation, reduces cell surface expression of c-Kit by direct repression of kit gene, impairs stem cell factor/c-Kit signaling, and compromises mechanisms that maintain HSC quiescence [27]. Beyond its role in adult hematopoiesis, YY1 is also indispensable for fetal hematopoietic development [26▪▪]. During embryogenesis, the fetal liver serves as the primary site of HSC expansion and maturation prior to their migration to the bone marrow (BM) [29,30]. Although the molecular mechanisms underlying the fetal-to-adult hematopoietic transition remain incompletely defined, YY1 has emerged as a critical regulator of this process. Conditional deletion of Yy1 in the fetal hematopoietic system leads to neonatal lethality and profound depletion of the fetal HSC pool. YY1-deficient fetal HSCs display defective migration, fail to engraft in the adult BM niche, and consequently lose their capacity to reconstitute hematopoiesis [26▪▪]. Transcriptomic analyses indicate that Yy1 loss disrupts gene networks involved in cell motility and adhesion in fetal HSPCs. Notably, YY1 does not directly bind to the promoters of most dysregulated genes in fetal HSPCs, suggesting predominantly indirect regulatory mechanisms [26▪▪]. Instead of direct binding at gene loci essential for cell mobility and locomotion, YY1 modulates chromatin accessibility at distal regulatory elements, thereby orchestrating broader epigenetic programs essential for HSPC migration and adhesion [26▪▪]. Collectively, these findings establish YY1 as a critical epigenetic regulator of HSC function across developmental stages and provide a mechanistic framework for understanding how temporally dynamic epigenomic configurations govern the fetal-to-adult transition of hematopoiesis. YIN YANG 1-DEPENDENT POLYCOMB GROUP REGULATION IN HEMATOPOIESIS YY1 is the mammalian orthologue of the Drosophila PcG protein Pleiohomeotic (Pho) and represents one of the few mammalian PcG proteins with intrinsic sequence-specific DNA-binding activity [10]. In addition to functioning as a conventional TF, YY1 mediates stable gene repression by recruiting PcG complexes to chromatin and promoting deposition of the repressive histone modification H3K27 trimethylation (H3K27me3) [10–13]. In mammals, most PcG proteins function within multiprotein complexes, primarily Polycomb Repressive Complex 1 (PRC1) and PRC2 [31]. Unlike canonical PRC1 and PRC2 components, YY1 is not a core subunit of these complexes but instead acts upstream to facilitate their recruitment to specific genomic loci [10–13]. A defining feature of YY1-mediated PcG function is the presence of a highly conserved 26–amino acid domain (residues 201–226), termed the REPO (REcruit POlycomb) domain. This domain is necessary and sufficient for recruitment of PcG proteins, including EZH2, to YY1-bound chromatin sites and for local induction of H3K27me3 [11–13]. Although a YY1 mutant lacking the REPO domain (YY1ΔREPO) retains DNA-binding capacity, transcriptional activation potential, transient repression activity, and interactions with coregulators such as HDACs, it is defective in PcG recruitment and PcG-dependent stable repression [10–12,32]. These findings established YY1 as a sequence-specific recruiter within the mammalian PcG epigenetic network, helping to resolve the longstanding question of how PcG complexes are targeted to defined genomic regions in the absence of intrinsic DNA-binding activity. PcG proteins play essential roles in HSC biology. Components of PRC1 and PRC2 – including BMI1, CBX7, RING1B, EZH2, EED, and SUZ12 – regulate HSC self-renewal, lineage commitment, and prevention of stem cell exhaustion [33–40]. For example, BMI1 is required for HSC self-renewal [33–35], while EZH2 overexpression preserves HSC potential during serial transplantation [36]. Consistent with this framework, YY1 and EZH2 exhibit striking functional parallels in hematopoietic development. Conditional deletion of either factor in the B cell lineage results in a developmental blockade at the pro-B stage with impaired distal V-to-DJ rearrangement [16,41], and YY1 co-localizes with EZH2 at the immunoglobulin κ locus [42]. Importantly, YY1-mediated B cell development is at least partially dependent on its PcG function, as deletion of the REPO domain fails to rescue YY1-null phenotypes and disrupts immunoglobulin (Ig)κ rearrangement [42]. In contrast to EZH2, which lacks intrinsic DNA-binding activity, YY1 directly binds target DNA sequences and recruits EZH2 to establish local H3K27me3 enrichment [11,12], positioning YY1 as a molecular bridge between sequence recognition and PcG-mediated epigenetic repression. Functional studies in hematopoiesis further demonstrate that YY1-dependent PcG activity is required for stem cell maintenance and balanced lineage output. The YY1 REPO domain is required for Igκ chain rearrangement during B cell development and early T cell survival [25,42]. In addition, the REPO domain is critical for long-term fetal liver HSC self-renewal in vivo [26▪▪]. Retroviral BM transplantation assays reveal that expression of a YY1ΔREPO in YY1-null HSPCs skews hematopoiesis toward myeloid differentiation at the expense of lymphoid development [25]. These findings indicate that YY1-mediated PcG recruitment is necessary to preserve proper lineage specification, stem cell homeostasis and lymphocyte development. Despite strong evidence supporting YY1 as a PcG recruiter, PcG targeting in mammalian cells is likely multifactorial. YY1 and PcG target genes do not completely overlap across cell types [21,43], and other TFs (e.g., GATA1, RUNX1, REST) and long non-coding RNAs have also been implicated in PcG recruitment [44–48]. Thus, YY1-dependent PcG repression appears to be context- and lineage-specific. YIN YANG 1 AS A CHROMATIN STRUCTURAL REGULATOR IN HEMATOPOIESIS Beyond its role in PcG recruitment, YY1 functions as a chromatin architectural factor that mediates long-range enhancer–promoter interactions and shapes three-dimensional (3D) genome organization. Gene expression frequently depends on physical proximity between distal cis-regulatory enhancers and target promoters, a process achieved through chromatin looping [49–52]. Classical architectural proteins such as CTCF and cohesin organize higher-order chromatin domains and stabilize loop structures [53–57]. More recently, YY1 has emerged as a sequence-specific looping factor capable of directly bridging enhancer and promoter elements through homodimerization, thereby facilitating transcriptional regulation via long-range chromatin interactions [3,6–8,9▪▪,17,19▪,58]. Structurally, the C-terminal zinc finger domain of YY1 mediates DNA binding, while the central region (amino acids 201–226, the REPO domain) enables PcG recruitment. Notably, the broader C-terminal portion of YY1 (aa 201–414) is also critical for chromatin looping functions, Ig class switching recombination [59] and XCI [18], indicating that YY1 integrates structural and epigenetic regulatory capacities within overlapping domains. Through these properties, YY1 operates not only as a TF but also as a dynamic organizer of chromatin topology. The architectural role of YY1 is particularly evident in B cell development. Conditional deletion of YY1 causes profound defects in B lymphopoiesis, including impaired progression from the pro-B to pre-B stage and reduced mature B cell output [7,16,21,42,59–61]. At the immunoglobulin loci, YY1 mediates long-distance DNA interactions required for V (D)J recombination and class-switch recombination (CSR) [7,16,23,42,59,62]. YY1 facilitates looping between the intronic Eμ enhancer and the 3΄ regulatory region (3΄RR), thereby promoting antibody diversification [59]. Mutational analyses demonstrate that a YY1 fragment encompassing amino acids 201–414, which retains DNA binding and the REPO domain but lacks the N-terminal activation domain, is sufficient to restore Eμ–3΄RR looping and rescue CSR [59]. YY1 also cooperates with cohesin and condensin complexes at the Igκ locus, and co-localizes with EZH2 at multiple regulatory regions, illustrating how chromatin architecture and PcG-dependent repression intersect during lymphoid development [42]. Genome-wide analyses further support a cooperative relationship between YY1, cohesin, and CTCF in HSPCs. YY1 physically interacts with CTCF and the cohesin component SMC3 through its C-terminal zinc finger domain [3,17,28,58], and chromatin profiling demonstrates extensive co-occupancy of these factors across the genome. Promoters co-bound by YY1, cohesin, and CTCF are enriched for genes involved in metabolic regulation, whereas cohesin/CTCF-bound loci lacking YY1 are more frequently associated with developmental programs [28]. These findings suggest that YY1 provides regulatory specificity within cohesin-CTCF-defined chromatin domains, contributing to context-dependent transcriptional outputs during HSC differentiation and metabolism. Consistent with this model, YY1-dependent chromatin organization also contributes to lineage fidelity. Loss of YY1 in pro-B cells disrupts stable B-lineage commitment, enabling altered differentiation into T cell and myeloid lineages. Multi-omic profiling indicates that YY1 deficiency increases chromatin accessibility at alternative lineage genes, suggesting that YY1 maintains lineage identity by constraining chromatin topology and enhancer accessibility [63▪▪]. Mechanistically, YY1-mediated enhancer–promoter contacts are frequently nested within stable CTCF-anchored domains, indicating that YY1 functions within pre-established topological frameworks to confer regulatory precision [4]. YY1 is required to establish a set of enhancer-promoter loops during G1 cell cycle stage in erythroid cells [9▪▪]. Emerging evidence further suggests that YY1 can promote transcriptional activation through phase-separated condensates that compartmentalize enhancers and coactivators, underscoring its role as a dynamic genome organizer [64]. Collectively, these findings position YY1 as a multifunctional chromatin organizer in hematopoiesis (Table 1). By coordinating enhancer–promoter looping, collaborating with cohesin and CTCF, and intersecting with PcG-mediated repression, YY1 integrates structural genome architecture with epigenetic regulation to maintain HSC identity, enforce lineage commitment, and support lymphoid differentiation (Fig. 1). Table 1YY1 functions as a chromatin architectural regulatorYY1 chromatin structural regulationMechanismReferenceCohesin / CTCF interaction and co-occupancyYY1 physically interacts with CTCF and SMC3 through its C-terminal zinc-finger domain. YY1 co-localizes with SMC3 and CTCF across the genome in HSPCs.[4,17,28,58]Enhancer–promoter loopingYY1 forms homo dimers that facilitate the interaction of active enhancers and proximal promoter elements. YY1 establishes enhancer–promoter loops in erythroid cells during G1-phase entry, highlighting a dynamic, cell-cycle-dependent architectural role.[3,4,6,8,9▪▪,19▪]Long-range chromatin interactions (LRCIs)YY1 cooperates with H3K27ac to mediate LRCIs to promote erythroid differentiation. YY1 orchestrates LRCIs and activation-associated chromatin remodeling across the Th2 cytokine locus[8,9▪▪,24]Igκ light-chain rearrangementThe YY1 PcG domain interacts with condensin and cohesin. YY1 co-localizes with EZH2 and condensin across the Igκ locus to support chromatin organization during recombination.[42]Ig heavy-chain CSRYY1 mediates long-distance interactions between the intronic Eμ enhancer and the 3΄ regulatory region (3΄RR) during CSR.[59]XCIYY1 maintains XCI in activated B cells through its C-terminal zinc-finger domain.[18]PcG-mediated functions in hematopoiesisYY1 PcG/REPO-dependent function is required for balanced lymphoid and myeloid lineage output. The REPO domain is critical for long-term fetal liver HSC self-renewal.[25,26▪▪]Transcriptional condensatesYY1 forms liquid-liquid phase-separated condensates to compartmentalize coactivators and enhancer elements for gene regulation. [64]Chromatin accessibilityLoss of YY1 in pro-B cells alters chromatin accessibility, repressing B-lineage genes while opening T-cell and myeloid loci, enabling altered differentiation. Deleting YY1 in fetal liver HSPCs alters global chromatin accessibility.[26▪▪,63▪▪]*This table is original. YY1 functions as a chromatin architectural regulator *This table is original. YY1 functions as a TF, PcG protein and chromatin structural regulator in hematopoiesis. YY1 can function as a canonical TF that binds directly to the promoters of target genes to regulate transcriptional activation (e.g., Kit or repression (e.g., Smc3) in HSPCs. YY1 can also recruit PcG proteins, such as EZH2, via its PcG domain to establish repressive chromatin marks H3K27me3 and stably repress transcription in B cells and HSCs. Furthermore, YY1 contributes to 3D chromatin architecture by forming homodimers and co-localizing with cohesin and CTCF. This complex establishes long-distance enhancer-promoter loops that activate gene transcription, particularly driving metabolic gene expression programs in HSPCs. YIN YANG 1 AND HEMATOPOIETIC STEM CELL AGING YY1 has emerged as a central regulator of aging across multiple tissues, including pancreatic β cells, the nervous system, and skeletal muscle [65▪,66▪,67]. In these settings, YY1 suppresses cellular senescence [68] and coordinates metabolic programs governing mitochondrial function and stress adaptation [69▪,70]. Notably, metabolic interventions such as betaine supplementation can restore YY1-dependent mitochondrial respiration and ameliorate age-associated mitochondrial dysfunction [71▪]. Collectively, these findings position YY1 at the intersection of metabolic regulation and cellular longevity. Metabolic reprogramming is a hallmark of HSC aging [72–74]. Aged HSCs exhibit increased proliferative activity, elevated reactive oxygen species (ROS), impaired mitochondrial function, and altered energy utilization – features closely linked to functional decline [72–75,76▪,77,78▪]. Concomitantly, the aging hematopoietic system is characterized by expansion of phenotypic HSC numbers, diminished long-term self-renewal capacity, and skewing toward myeloid lineage output [79–83]. The convergence of metabolic dysregulation and HSC dysfunction suggests the involvement of upstream regulators that integrate metabolic homeostasis with HSC functions. Accumulating evidence identifies YY1 as a critical component of this regulatory axis. Genome-wide occupancy analyses demonstrate that genomic regions co-bound by YY1, cohesin, and CTCF are enriched for metabolic gene programs in HSPCs [28], implicating YY1 function in higher-order chromatin organization of metabolic networks. Consistent with this, loss-of-function studies have shown that YY1 deficiency in HSCs results in hyperproliferation, metabolic rewiring, elevated ROS levels, and compromised mitochondrial function – phenotypes that recapitulate key features of aged HSCs [26▪▪,27,28]. Moreover, YY1 expression and activity decline with age in murine HSCs [84▪▪], and restoring YY1 expression rescues long-term self-renewal capacity in aged HSCs [85]. In addition, several key signature genes associated with HSC aging, including Itgb3, Vwf, and Neo1[86], intersect with YY1-dependent regulatory programs [87▪,88▪,89], reinforcing the concept that diminished YY1 activity contributes to age-associated hematopoietic decline. Although age-associated chromatin remodeling in HSCs has been documented [90,91▪▪], how aging reshapes higher-order genome architecture and drives functional decline remains unclear. Given YY1's roles as a TF, PcG protein, and structural regulator mediating enhancer–promoter looping, it is well-positioned to link metabolic gene expression with 3D chromatin organization. Future work should clarify how YY1 cooperates with architectural complexes such as cohesin, condensin, and CTCF to maintain chromatin loops and regulatory hubs that support HSC quiescence and metabolism. Key questions include whether age-related YY1 reduction disrupts chromatin topology at metabolic and stemness loci and whether restoring YY1 can rejuvenate chromatin structure and function. Combining single-cell multi-omics, high-resolution chromatin conformation mapping, and functional assays will be critical. Understanding YY1-dependent chromatin architecture may provide a mechanistic framework for HSC aging and reveal strategies to restore youthful hematopoiesis. CONCLUSION As a multifunctional TF, YY1 governs HSC quiescence, self-renewal, and lineage commitment by integrating PcG-mediated repression with high-order chromatin structure. Emerging evidence further identifies YY1 as a key regulator of HSC aging, linking changes in chromatin organization and metabolic homeostasis to progressive stem cell dysfunction. Collectively, these findings position YY1 as a key factor connecting epigenetic regulation, 3D genome architecture, and stem cell longevity and underscore the need to dissect YY1's functions across development and aging to better understand age-associated hematopoietic decline. Acknowledgements This research was supported by NIH grants R03OD026603 and R01HL146540 awarded to X.P. Financial support and sponsorship None. Conflicts of interest There are no conflicts of interest. REFERENCES AND RECOMMENDED READING Papers of particular interest, published within the annual period of review, have been highlighted as: ▪ of special interest ▪ of special interest ▪▪ of outstanding interest ▪▪ of outstanding interest REFERENCES